Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple quiz could spot Parkinson's pain

NCT ID NCT03940872

Diagnosis Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study developed and tested a self-questionnaire called the 3PDQ to help diagnose pain that is directly caused by Parkinson's disease, rather than from other causes. Researchers enrolled 227 Parkinson's patients with chronic pain and compared their questionnaire answers with a doctor's exam. The goal is to give doctors a quick, reliable tool to identify Parkinson's-related pain and improve treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
3PDQ self-questionnaire (diagnostic test)
What this could lead to
If successful, this questionnaire could give doctors a simple, reliable tool to identify pain directly caused by Parkinson's disease, improving pain management.
What could go wrong
This is a small, completed study in French only, so the questionnaire may not work as well in other languages or populations. It is a diagnostic tool, not a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

227 people

The number who actually took part.

Started

Apr 2019

Finished

Dec 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with Parkinson Disease (PD) * Patients who have chronic pain (for at least 3months) moderate to severe (intensity ≥ 4/10 on visual analogue scale from 0 to 10) specific or unspecific to PD * Patients who have one type of pain or different type of pain: in this case, patients should suffered from one predominant pain and be able to identify it * Patients who have stable analgesic medication during the study * Patients who understand and speak fluently French * Patients with health insurance * Patients who signed the written informed consent form Exclusion Criteria: * Patients with severe depression according to Diagnostic and Statistical Manual (DSM) V criteria * Analgesic medication modified recently (less than 1month) * Patients with psycho-actives substances or alcohol abused * Patients with cognitive impairment (MoCA score \< 25)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Parkinson disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

disease Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Parkinson disease

Contacts and locations

Locations

  • Neurolgoy service

    Nancy, France

  • Neurology Service

    Montpellier, France

  • Neurology service

    Clermont-Ferrand, France

  • Neurology service

    Lille, France

  • Neurology service

    Lyon, France

  • Neurology service

    Marseille, France

  • Neurology service

    Nantes, France

  • Neurology service

    Rouen, France

  • Neurology service

    Strasbourg, France

  • Neurology service

    Toulouse, 31059, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.